(Q45491056)

14 December 2017

title

Primary infection of mice with high titer inoculum respiratory syncytial virus: characterization and response to antiviral therapy. (English)

1 reference

14 December 2017

Gordon Bolger

1

1 reference

14 December 2017

Nicole Lapeyre

2

1 reference

14 December 2017

Nathalie Dansereau

3

1 reference

14 December 2017

Lisette Lagacé

4

1 reference

14 December 2017

Gerald Berry

5

1 reference

14 December 2017

Katy Klosowski

6

1 reference

14 December 2017

Tracy Mewhort

7

1 reference

14 December 2017

Michel Liuzzi

8

1 reference

14 December 2017

publication date

1 February 2005

1 reference

Canadian Journal of Physiology and Pharmacology

14 December 2017

published in

1 reference

14 December 2017

volume

83

1 reference

14 December 2017

issue

2

1 reference

14 December 2017

page(s)

198-213

1 reference

Pathological changes in virus infections of the lower respiratory tract in children

14 December 2017

cites work

1 reference

Respiratory syncytial virus infection of human primary nasal and bronchial epithelial cell cultures and bronchoalveolar macrophages

21 January 2018

1 reference

Cytokine and chemokine gene expression after primary and secondary respiratory syncytial virus infection in cotton rats

21 January 2018

1 reference

Effect of lack of Interleukin-4, Interleukin-12, Interleukin-18, or the Interferon-gamma receptor on virus replication, cytokine response, and lung pathology during respiratory syncytial virus infection in mice

21 January 2018

1 reference

Immunological mechanisms of severe respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

Molecular detection of respiratory syncytial virus in postmortem lung tissue samples from Mexican children deceased with pneumonia

21 January 2018

1 reference

Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines

21 January 2018

1 reference

Therapy of respiratory syncytial virus infection

21 January 2018

1 reference

MIP-1alpha is produced but it does not control pulmonary inflammation in response to respiratory syncytial virus infection in mice.

21 January 2018

1 reference

Early ribavarin treatment of bronchiolitis: effect on long-term respiratory morbidity.

21 January 2018

1 reference

High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection

21 January 2018

1 reference

Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

Further studies with short duration ribavirin aerosol for the treatment of influenza virus infection in mice and respiratory syncytial virus infection in cotton rats

21 January 2018

1 reference

Primary respiratory syncytial virus infection in mice

21 January 2018

1 reference

Immune-mediated disease pathogenesis in respiratory syncytial virus infection

21 January 2018

1 reference

Early ribavirin treatment of respiratory syncytial viral infection in high-risk children

21 January 2018

1 reference

Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1alpha in lung pathology

21 January 2018

1 reference

Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways

21 January 2018

1 reference

Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study

21 January 2018

1 reference

Interleukin 12 deficiency associated with recurrent infections

21 January 2018

1 reference

An outbreak of respiratory syncytial virus in a bone marrow transplant center

21 January 2018

1 reference

Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation

21 January 2018

1 reference

In vivo production of tumour necrosis factor-alpha and interleukin-6 in BALB/c mice inoculated intranasally with a high dose of respiratory syncytial virus

21 January 2018

1 reference

Neutralizing anti-F glycoprotein and anti-substance P antibody treatment effectively reduces infection and inflammation associated with respiratory syncytial virus infection

21 January 2018

1 reference

Cytokines and chemokines in respiratory secretion and severity of disease in infants with respiratory syncytial virus (RSV) infection

21 January 2018

1 reference

Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology

21 January 2018

1 reference

Role of chemokines in respiratory syncytial virus disease

21 January 2018

1 reference

Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus

21 January 2018

1 reference

A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine

21 January 2018

1 reference

Intranasal IFN-gamma gene transfer protects BALB/c mice against respiratory syncytial virus infection

21 January 2018

1 reference

Respiratory syncytial virus predisposes mice to augmented allergic airway responses via IL-13-mediated mechanisms

21 January 2018

1 reference

Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein

21 January 2018

1 reference

Immunity and immunopathology to respiratory syncytial virus. The mouse model

21 January 2018

1 reference

Palivizumab is highly effective in suppressing respiratory syncytial virus in an immunosuppressed animal model

21 January 2018

1 reference

Characteristics of a respiratory syncytial virus persistently infected macrophage-like culture

21 January 2018

1 reference

Effect of ribavirin on viral hepatitis in laboratory animals

21 January 2018

1 reference

Primary respiratory syncytial virus infection: pathology, immune response, and evaluation of vaccine challenge strains in a new mouse model

21 January 2018

1 reference

Genetic susceptibility to respiratory syncytial virus infection in inbred mice

21 January 2018

1 reference

Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile.

21 January 2018

1 reference

Role of interleukin-12 and stat-4 in the regulation of airway inflammation and hyperreactivity in respiratory syncytial virus infection

21 January 2018

1 reference

Respiratory syncytial virus G and/or SH glycoproteins modify CC and CXC chemokine mRNA expression in the BALB/c mouse

21 January 2018

1 reference

Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice

21 January 2018

1 reference

Beta-chemokines, but neither T helper type 1 nor T helper type 2 cytokines, correlate with severity of illness during respiratory syncytial virus infection

21 January 2018

1 reference

Role of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c mice

21 January 2018

1 reference

Computer assisted recognition and quantitation of the effects of airborne chemicals acting at different areas of the respiratory tract in mice.

21 January 2018

1 reference

Replication and clearance of respiratory syncytial virus: apoptosis is an important pathway of virus clearance after experimental infection with bovine respiratory syncytial virus

21 January 2018

1 reference

Use of cotton rats to evaluate the efficacy of antivirals in treatment of measles virus infections

21 January 2018

1 reference

The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses

21 January 2018

1 reference

Pathogenesis of pneumovirus infections in mice: detection of pneumonia virus of mice and human respiratory syncytial virus mRNA in lungs of infected mice by in situ hybridization

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1139/Y05-007

1 reference

14 December 2017

1 reference